Tokyo, Sept. 16 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062926) titled 'Effects verified through wearing of Wellveil: an open-label study' on Sept. 15.

Study Type: Interventional

Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Uncontrolled

Primary Sponsor: Institute - LUHTA SPORTSWEAR JAPAN G.K.

Condition: Condition - Healthy Japanese Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To verify the effects of wearing of the test product on skin condition in healthy Japanese. Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - Duration: 8 weeks Test product: Wellveil Administration: Wear it all day (24 hours). Participants may change clothes at any time they choose, and there are no restrictions on washing methods or detergent types. *If the participant forgets to wear it, they should do so as soon as they realize it.

Eligibility: Age-lower limit - 40 years-old = Gender - Male and Female Key inclusion criteria - 1. Japanese

2. Men or women

3. Individuals aged between 40 and 50

4. Healthy individuals Key exclusion criteria - 1. Individuals who are receiving treatment for or have a history of malignant tumors, heart failure, or myocardial infarction

2. Individuals who have an implanted pacemaker or implantable cardioverter defibrillator

3. Individuals who are currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disorder, chronic kidney disease, cerebrovascular disorder, rheumatic disease, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases

4. Individuals who have a current medical history of atopic dermatitis

5. Individuals who consume Foods for Specified Health Uses or Foods with Functional Claims

6. Individuals who are taking or using medications (including herbal medicines) or supplements

7. Individuals who are allergic to medications or foods related to the test food (particularly metal)

8. Individuals who are pregnant, lactating, or planning pregnancy during this study

9. Individuals who are deemed unsuitable for participation in this study by the principal investigator Target Size - 5

Recruitment Status: Recruitment status - Open public recruiting Date of protocol fixation - 2026 Year 09 Month 09 Day Date of IRB - 2026 Year 09 Month 09 Day Anticipated trial start date - 2026 Year 09 Month 15 Day Last follow-up date - 2026 Year 12 Month 25 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072045

Disclaimer: Curated by HT Syndication.